About
Breast Cancer Prediction Technology
Areas of Focus
Categories
DiagnosticsPoland
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
0
As Collaborator
8
Total Enrollment
32,601
By Phase
NA: 3PHASE1: 2PHASE2: 1
By Status
COMPLETED: 2ACTIVE_NOT_RECRUITING: 2UNKNOWN: 2WITHDRAWN: 1RECRUITING: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06008301Collaborator
Comparing Breast Magnetic Resonance Imaging (MRI) and Contrast-enhanced Mammography (CEM)
NAWithdrawn
Started: Apr 30, 2025 · Completed: Jun 30, 2027
NCT04360941Collaborator
PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer
PHASE1Recruiting
45 participants
Started: Aug 11, 2020 · Completed: Jul 31, 2026
NCT04173897Collaborator
Living Better With Advanced Breast Cancer: Feasibility Evaluation of an Online Supportive Intervention.
NACompleted
41 participants
Started: Jun 6, 2020 · Completed: Mar 31, 2021
NCT04359420Collaborator
What Are the Benefits and Harms of Risk Stratified Screening in the NHS Breast Screening Programme: Study Protocol
NACompleted
32,298 participants
Started: Aug 1, 2019 · Completed: Jun 30, 2022
NCT03620643Collaborator
Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours
PHASE2Active, not recruiting
58 participants
Started: May 9, 2019 · Completed: Jul 1, 2024
Locations (1)
Headquarters
Kraków, Poland
Map
Loading map...